Alumnus Dr. Brian Feagan's REACT clinical trial supports new approach to accelerated treatment for Crohn's disease

Monday, March 3, 2014

Robarts Clinical Trials has announced the final results from an international clinical trial involving nearly 2,000 patients with Crohn’s disease.


Read the rest of the article...